Multiple myeloma shows no intra-disease clustering of immunoglobulin heavy chain genesFERRERO, Simone; CAPELLO, Daniela; ZANNI, Manuela et al.Haematologica (Roma). 2012, Vol 97, Num 6, pp 849-853, issn 0390-6078, 5 p.Article

The host genetic background of DNA repair mechanisms is an independent predictor of survival in diffuse large B-cell lymphomaROSSI, Davide; RASI, Silvia; BRUNA, Riccardo et al.Blood. 2011, Vol 117, Num 8, pp 2405-2413, issn 0006-4971, 9 p.Article

Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignanciesCORRADINI, Paolo; TARELLA, Corrado; CICERI, Fabio et al.Blood. 2002, Vol 99, Num 1, pp 75-82, issn 0006-4971Article

Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis : the superior disease control of R-HDS does not translate into an overall survival advantageLADETTO, Marco; DE MARCO, Federica; GALLAMINI, Andrea et al.Blood. 2008, Vol 111, Num 8, pp 4004-4013, issn 0006-4971, 10 p.Article

The new tumor-suppressor gene inhibitor of growth family member 4 (ING4) regulates the production of proangiogenic molecules by myeloma cells and suppresses hypoxia-inducible factor-1 a (HIF-1α) activity : involvement in myeloma-induced angiogenesisCOLLA, Simona; TAGLIAFERRI, Sara; BONOMINI, Sabrina et al.Blood. 2007, Vol 110, Num 13, pp 4464-4475, issn 0006-4971, 12 p.Article

Patients with high-risk aggressive lymphoma treated with frontline intensive chemotherapy and autografting: Evidence of marked differences in outcome between patients with age-adjusted International Prognostic Index scores 2 and 3CUTTICA, Alessandra; ZALLIO, Francesco; BOCCADORO, Mario et al.Cancer. 2003, Vol 98, Num 5, pp 983-992, issn 0008-543X, 10 p.Article

MET dysregulation is a hallmark of aggressive disease in multiple myeloma patientsROCCI, Alberto; GAMBELLA, Manuela; ISAIA, Gianluca et al.British journal of haematology. 2014, Vol 164, Num 6, pp 841-850, issn 0007-1048, 10 p.Article

Dysfunctional Vγ9Vδ2 T cells are negative prognosticators and markers of dysregulated mevalonate pathway activity in chronic lymphocytic leukemia cellsCOSCIA, Marta; VITALE, Candida; GUARINI, Anna et al.Blood. 2012, Vol 120, Num 16, pp 3271-3279, issn 0006-4971, 9 p.Article

Telomere loss in Philadelphia-negative hematopoiesis after successful treatment of chronic myeloid leukemia: Evidence for premature aging of the myeloid compartmentLOBETTI-BODONI, Chiara; FERRERO, Dario; DRANDI, Daniela et al.Mechanisms of ageing and development. 2012, Vol 133, Num 7, pp 479-488, issn 0047-6374, 10 p.Article

MLN3897, a novel CCR1 inhibitor, impairs osteoclastogenesis and inhibits the interaction of multiple myeloma cells and osteoclastsVALLET, Sonia; RAJE, Noopur; OCIO, Enrique M et al.Blood. 2007, Vol 110, Num 10, pp 3744-3752, issn 0006-4971, 9 p.Article

Interim 18-FDG-PET/CT failed to predict the outcome in diffuse large B-cell lymphoma patients treated at the diagnosis with rituximab-CHOPPREGNO, Patrizia; CHIAPPELLA, Annalisa; NICOLOSI, Maura et al.Blood. 2012, Vol 119, Num 9, pp 2066-2073, issn 0006-4971, 8 p.Article

Stereotyped B-Cell Receptor Is an Independent Risk Factor of Chronic Lymphocytic LeukemiaTransformation to Richter SyndromeROSSI, Davide; SPINA, Valeria; ZUCCA, Emanuele et al.Clinical cancer research (Print). 2009, Vol 15, Num 13, pp 4415-4422, issn 1078-0432, 8 p.Article

Long-term follow-up of indolent lymphoma patients treated with high-dose sequential chemotherapy and autografting: Evidence that durable molecular and clinical remission frequently can be attained only in follicular subtypesCARRADINI, Paolo; LADETTO, Marco; BENEDETTI, Fabio et al.Journal of clinical oncology. 2004, Vol 22, Num 8, pp 1460-1468, issn 0732-183X, 9 p.Article

High rate of clinical and molecular remissions in follicular lymphoma patients receiving high-dose sequential chemotherapy and autografting at diagnosis: a multicenter, prospective study by the Gruppo Italiano Trapianto Midollo Osseo (GITMO)LADETTO, Marco; CORRADINI, Paolo; FIORITONI, Giuseppe et al.Blood. 2002, Vol 100, Num 5, pp 1559-1565, issn 0006-4971, 7 p.Article

Genome-wide DNA profiling better defines the prognosis of chronic lymphocytic leukaemiaRINALDI, Andrea; MIAN, Michael; LADETTO, Marco et al.British journal of haematology. 2011, Vol 154, Num 5, pp 590-599, issn 0007-1048, 10 p.Article

Low CD49d expression and long telomere identify a chronic lymphocytic leukemia subset with highly favourable outcomeROSSI, Davide; LOBETTI BODONI, Chiara; ZUCCHETTO, Antonella et al.American journal of hematology. 2010, Vol 85, Num 8, pp 619-622, issn 0361-8609, 4 p.Article

Pcr-detectable nonneoplastic Bcl-2/IgH rearrangements are common in normal subjects and cancer patients at diagnosis but rare in subjects treated with chemotherapyLADETTO, Marco; DRANDI, Daniela; FALCO, Patrizia et al.Journal of clinical oncology. 2003, Vol 21, Num 7, pp 1398-1403, issn 0732-183X, 6 p.Article

Qualitative and quantitative polymerase chain reaction detection of the residual myeloma cell contamination after positive selection of CD34⁺ cells with small- and large-scale Miltenyi cell sorting systemVOENA, Claudia; LOCATELLI, Giovanni; LUSSO, Paolo et al.British journal of haematology. 2002, Vol 117, Num 3, pp 642-645, issn 0007-1048Article

Rituximab Maintenance Compared With Observation After Brief First-Line R-FND Chemoimmunotherapy With Rituximab Consolidation in Patients Age Older Than 60 Years With Advanced Follicular Lymphoma: A Phase III Randomized Study by the Fondazione Italiana LinfomiVITOLO, Umberto; LADETTO, Marco; DE RENZO, Amalia et al.Journal of clinical oncology. 2013, Vol 31, Num 27, pp 3351-3359, issn 0732-183X, 9 p.Article

CD49d expression is an independent risk factor of progressive disease in early stage chronic lymphocytic leukemiaROSSI, Davide; ZUCCHETTO, Antonella; BULIAN, Pietro et al.Haematologica (Roma). 2008, Vol 93, Num 10, pp 1575-1579, issn 0390-6078, 5 p.Article

Cyclooxygenase-2 (COX-2) is frequently expressed in multiple myeloma and is an independent predictor of poor outcomeLADETTO, Marco; VALLET, Sonia; CAVALLO, Federica et al.Blood. 2005, Vol 105, Num 12, pp 4784-4791, issn 0006-4971, 8 p.Article

Telomere length correlates with histopathogenesis according to the germinal center in mature B-cell lymphoproliferative disordersLADETTO, Marco; COMPAGNO, Mara; VALLET, Sonia et al.Blood. 2004, Vol 103, Num 12, pp 4644-4649, issn 0006-4971, 6 p.Article